Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Three Featured Products Upgraded at Alfa Chemistry: Protection Reagents, Environmental Goods Standards, Porphyrins and Phthalocyanines

    Dec 14, 2022, 09:45 AM by
    On the occasion of Thanksgiving and Christmas, Alfa Chemistry would like to express its sincere gratitude to its global customers. In addition to discounts and exquisite gifts offered to ordering customers, the company also continuously improves its product lines. Fairly recently, Alfa Chemistry announced the upgrade of its featured products, i.e., protection reagents, environmental goods standards, as well as porphyrins and phthalocyanines, supporting better user experience and wider choices for customers across the world.
    Full story
  • CD Formulation Launches One-stop OEM/ODM and Analytical Testing Solutions for Cosmetics

    Dec 14, 2022, 09:43 AM by
    The past decade has seen exponential growth of the cosmeceutical market in the personal care industry. There is increasing use of alpha hydroxy acids for skin rejuvenation as well as the use of vitamin C in topical formulations as an antioxidant. In response to such a trend, CD Formulation recently launched one-stop OEM/ODM and analytical testing solutions for cosmetic formulations.
    Full story
  • Curebase Releases Diagnostic Offering that Delivers First All-Inclusive Package of Software and Services Needed to Fully Execute Diagnostic Studies

    Dec 14, 2022, 09:40 AM by
    Start-up trials achieved in eight to 12 weeks, a fraction of typical timeframe
    Full story
  • InsightRX Provides Máxima Medical Center with Precision Dosing Guidance

    Dec 14, 2022, 09:38 AM by
    Large teaching hospital in the Netherlands relies on precision dosing platform for point-of-care decision support and immunology research
    Full story
  • Triad HealthCare Network Harnesses Medication Data to Improve Outcomes for High-Risk Patients

    Dec 14, 2022, 09:37 AM by
    DrFirst’s MedHx PRM Provides Quick Access to Prescription Fill Information So Healthcare Providers Can Intervene Early to Prevent Readmissions and Optimize Outcomes
    Full story
  • In Virtual Trials, Two Alzheimer’s Drugs Do Poor Job Of Slowing Cognitive Decline

    Dec 14, 2022, 01:00 AM by User Not Found
    Bio-IT World | Researchers from Duke, Penn State, and the University of Tennessee collaboratively built a mathematical model of Alzheimer’s disease that used real, de-identified patient data to simulate health outcomes from a pair of anti-amyloid-beta drugs. Notably, the virtual (aka in silico) clinical trials employed a computational approach that provides “individualized prescriptions” based on optimal timing and dosing of treatment while minimizing possible side effects.
    Full story
  • CluePoints Appoints Andy Cooper as New Chief Executive Officer

    Dec 13, 2022, 10:50 AM by
    CluePoints Appoints Andy Cooper as New Chief Executive Officer New CEO brings a combination of experience and drive as CluePoints rapidly scales its RBQM and Data Quality Oversight offerings
    Full story
  • Inizio acquires Evolution Road, bolstering Evoke’s digital innovation and omnichannel offering

    Dec 13, 2022, 10:47 AM by
    Full story
  • All of Us Announces First Return of Health-Related DNA Results

    Dec 13, 2022, 10:00 AM by User Not Found
    Bio-IT World | The National Institutes of Health's All of Us Research Program has begun returning personalized health-related DNA results to more than 155,000 participants, with reports detailing whether participants have an increased risk for specific health conditions and how their body might process certain medications.
    Full story
  • Pregnancy Exposome A New Frontier In Personalized Medicine

    Dec 13, 2022, 01:00 AM by User Not Found
    Bio-IT World | The importance of the pregnancy exposome on health was explored in depth by Barbara Cohn, Ph.D., director and senior research scientist at the Public Health Institute, at the Mayo Clinic’s recent Individualizing Medicine Conference. She has been an integral part of a groundbreaking, multigenerational study examining the ripple effects of chemical exposures on pregnant women and their offspring and the potential for metabolomics to drive individualized prevention and treatment.
    Full story
  • Icosagen Chooses Genedata Biologics to Digitalize Recombinant Antibody Discovery

    Dec 12, 2022, 18:00 PM by
    Leading CRDMO implements market-leading platform to streamline its biotherapeutics discovery workflow and data exchange with biopharma customers
    Full story
  • MultiCare Partners with IllumiCare to Offer Clinical Trials at Point-of-Care with Trials App

    Dec 12, 2022, 17:48 PM by
    MultiCare Health System is the first to use the Illumicare Trials App in a clinical setting, streamlining clinical trial recruitment and increasing awareness among providers, patients and clinical research teams.
    Full story
  • Digital Therapeutics Alliance and Curebase release publication setting the stage for a fit-for-purpose evidence standard for digital therapeutics (DTx)

    Dec 12, 2022, 17:48 PM by
    Digital Therapeutics Alliance and Curebase release publication setting the stage for a fit-for-purpose evidence standard for digital therapeutics (DTx)
    Full story
  • Tesis Biosciences Announces Proposed Study of Veterans and Civilians with Mild Traumatic Brain Injury

    Dec 12, 2022, 17:48 PM by
    Tesis Biosciences Announces Proposed Study of Veterans and Civilians with Mild Traumatic Brain Injury - Company in preparation for formal FDA approval submission
    Full story
  • New Draper Study Showcases Powerful New Way to Evaluate Kidney Toxicity

    Dec 12, 2022, 17:47 PM by
    A new study by scientists at Draper adds to the toolbox researchers can use in understanding the biological processes underway in organ-chips. They discovered a new indicator of toxicity in kidney-chips.
    Full story
  • ScyTek announces a new special stain kit, The Martius Scarlet Blue (MSB) Stain Kit.

    Dec 12, 2022, 17:47 PM by
    Scytek Laboratories Inc - The Martius Scarlet Blue (MSB) stain kit is intended for use in the histological demonstration of fibrin, muscle, collagen, and erythrocytes. MSB is a reliable method of differentiating fresh and old fibrin clusters.
    Full story
  • CATALOG Achieves Historic DNA Computing Milestone

    Dec 12, 2022, 17:47 PM by
    Full story
  • Endor Labs Unveils New Research on Impact of Open Source Software on Supply Chain Security

    Dec 9, 2022, 10:50 AM by
    Endor Labs—a startup taking on the issue of unsecured open source sprawl for healthcare institutions and organizations of every kind – released new research exploring the impact of open source software on supply chain security.
    Full story
  • Inozyme Pharma Announces Peer-Reviewed Publication Revealing Increased Prevalence of ENPP1 Deficiency

    Dec 9, 2022, 10:45 AM by
    Leading disease experts and Genomenon published an article titled “Estimation of ENPP1 Deficiency Genetic Prevalence Using a Comprehensive Literature Review and Population Databases” in the Orphanet Journal of Rare Diseases
    Full story
  • Qlucore announces software upgrade to facilitate improved single cell data analysis

    Dec 9, 2022, 10:44 AM by
    Qlucore, a leading provider of powerful visualization-based bioinformatics data analysis tools, announces an upgrade to its Qlucore Omics Explorer (QOE) software. The upgrade adds features and functionality for easier data import and analysis of single cell data.
    Full story
  • «
  • 101 (current)
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy